Corteva forecasts $4.1B-$4.3B operating EBITDA and targets October 1 separation date

Earnings Call Insights: Corteva (CTVA) Q2 2026

MANAGEMENT VIEW

* "The headline for this quarter is straightforward. We are delivering strong results. We are raising our full year outlook, and we are on track to complete our separation on October 1." (CEO & Director Charles Magro)
* "In the first half, net sales increased 4%, operating EBITDA increased 10% and operating EPS increased 14%." (CEO & Director Magro)
* "We now expect operating EBITDA of $4.1 billion to $4.3 billion and operating EPS of $3.60 to $3.80 per share." (CEO & Director Magro)
* "We introduced Vylor as the name of the future advanced Seed and genetics company, completed key leadership appointments, publicly filed the Form 10, appointed both Boards of Directors and engaged with credit rating agencies regarding our planned capital structures." (CEO & Director Magro)
* "Regarding dissynergies, I'm happy to report that on a run rate basis, we've largely offset the impact of separation." (CEO & Director Magro)
* "For the quarter, net sales were $6.4 billion, while operating EBITDA increased 4% to $2.3 billion." (Executive VP & CFO David Johnson)
* "Margin expanded to 32.8%, driven by continued value capture in Seed, productivity improvements across both businesses and disciplined cost management." (Executive VP & CFO Johnson)

OUTLOOK

* "We now expect operating EBITDA between $4.1 billion and $4.3 billion" and "operating EBITDA margin outlook to a range of 22.5% to 23.5%." (Executive VP & CFO Johnson)
* "We've raised our operating EPS guidance to a range of $3.60 to $3.80 per share." (Executive VP & CFO Johnson)
* "Within Seed, we continue to expect low single-digit organic sales growth." (Executive VP & CFO Johnson)
* "Within Crop Protection, volumes are expected to grow at a high single-digit rate" while "pricing is anticipated to decline in the low to mid-single digits." (Executive VP & CFO Johnson)
* "We expect Brazil corn area to remain approximately flat." (Executive VP & CFO Johnson)
* Compared with Q1 2026, management moved from "operating EBITDA in the range of $4 billion to $4.2 billion" and "operating EPS of $3.45 to $3.70" to the higher full-year ranges stated in Q2. (Executive VP & CFO Johnson)

FINANCIAL RESULTS

* "For the quarter, net sales were $6.4 billion" and "operating EBITDA increased 4% to $2.3 billion." (Executive VP & CFO Johnson)
* "Looking at the first half, net sales increased 4% to $11.3 billion" and "operating EBITDA to $3.7 billion, an increase of 10% over prior year." (Executive VP & CFO Johnson)
* "Operating EBITDA increased approximately $350 million year-over-year to $3.7 billion" including "Cost performance" of "more than $160 million," "currency" benefit of "approximately $85 million," and "approximately $90 million of improved seed net royalties." (Executive VP & CFO Johnson)
* "As expected, first half cash flow was impacted by the Bayer agreement, onetime separation items and the pension contribution announced last quarter." (Executive VP & CFO Johnson)
* "We anticipate a typical seasonal earnings pattern in the second half with the third quarter operating EBITDA loss in the range of what we saw in 2024 and all second half earnings delivered in the fourth quarter." (Executive VP & CFO Johnson)

Q&A

* Vincent Andrews, Morgan Stanley: asked what drives the company’s "expecting flat corn acres" in Brazil and what it anticipates on "pricing and mix" and "Conkesta penetration"; CEO & Director Magro said the "order book is on pace" and "actually ahead of the market," adding "we think we're going to be high single digits, low double digits in terms of penetration in the market with Conkesta E3 in 2027." (CEO & Director Magro)
* Christopher Parkinson, Wolfe Research: asked what Luke Kissam is "most excited about" for the longer-term narrative; Chief Executive Officer of Crop Protection Business Luther Kissam said "2/3 of our current portfolio is a differentiated technology" and called it "the best crop protection pipeline in the business with 7 new actives coming into that market over the next decade." (Chief Executive Officer of Crop Protection Business Kissam)
* Joel Jackson, BMO: asked whether the prior 2027 EBITDA target implies "mid-single-digit growth"; management said "$4.2 billion fits us very comfortably" versus the prior "$4.4 billion" view, and highlighted "licensing is literally 3 years ahead of our original plan" and "that new product portfolio... it's going to touch $2 billion this year in revenue." (Chief Executive Officer of Crop Protection Business Kissam; CEO & Director Magro)
* Matthew Hettwer, Vertical Research Partners: asked to unpack weaker trends in core Crop Protection categories; CEO & Director Magro said the market view is unchanged, cited "more competitive pressure in Brazil," and pointed to the upcoming fungicide "Haviza" as "a blockbuster fungicide." (CEO & Director Magro)
* David Begleiter, Deutsche Bank: asked about North America share gains; CEO & Director Magro said the company "picked up a little bit of share in corn" and in soy "we picked up share" in parts of the Corn Belt but "gave up a little bit of share" in the Delta, concluding "in soy... pretty flat" and "in corn... picked up a tick of share." (CEO & Director Magro)
* Edlain Rodriguez, Mizuho: asked if steep Latin America pricing pressure is "the new normal"; CEO & Director Magro said "we don't think that the high single-digit pricing pressure is the new normal in Brazil" and added "we're not expecting price recovery in Brazil in 2026." (CEO & Director Magro)

SENTIMENT ANALYSIS

* Analysts’ tone was slightly negative to skeptical on pricing, seasonality, and Brazil credit, including questions on whether pressure is "the new normal" and why Q4 would be more heavily weighted. (Edlain Rodriguez, Mizuho; Lucas Beaumont, UBS)
* Management’s tone was slightly positive and operationally confident, repeatedly emphasizing execution and separation progress, including "we are raising our full year outlook" and "on track and executing according to plan, on time and under budget." (CEO & Director Magro)
* Versus Q1 2026, management language shifted from reaffirming guidance to raising it, and from a broad Q4 separation window to a specific "October 1" target date. (CEO & Director Magro; Executive VP & CFO Johnson)

QUARTER-OVER-QUARTER COMPARISON

* Guidance shifted upward from Q1’s "$4 billion to $4.2 billion" operating EBITDA and "$3.45 to $3.70" operating EPS to Q2’s "$4.1 billion to $4.3 billion" and "$3.60 to $3.80." (Executive VP & CFO Johnson)
* Separation messaging tightened from Q1’s "sometime in the fourth quarter" to Q2’s "targeting October 1" with Vylor "beginning operations as a separate public company." (CEO & Director Magro)
* Q2 placed more emphasis on dissynergy mitigation, stating "on a run rate basis, we've largely offset the impact of separation" and citing "something in the range of a $25 million headwind this year" tied to timing. (CEO & Director Magro)

RISKS AND CONCERNS

* "Ongoing pricing pressure in pockets of the crop protection market" remained a focus, with management flagging Brazil and "1 or 2 other pockets." (CEO & Director Magro)
* Management cited external risks including "geopolitical uncertainty" and "ongoing foreign exchange movements," and added that second-half results reflect the back-half weighting of "tariffs, dissynergies and the Middle East conflict." (Executive VP & CFO Johnson)
* In Brazil Seed, management said "credit is tight for the Brazilian farmer right now" and framed it as something to "continue to manage." (CEO & Director Magro)

FINAL TAKEAWAY

Management framed Q2 as a pivot from reaffirmation to an increased full-year outlook, pairing higher operating EBITDA, margin, and operating EPS ranges with a defined October 1 separation target. Executives repeatedly emphasized that Seed technology adoption, licensing momentum, and Crop Protection new products and productivity actions are expected to support results even as Brazil pricing pressure and farmer-credit conditions remain active watch items into the second half.

Read the full Earnings Call Transcript [https://seekingalpha.com/symbol/ctva/earnings/transcripts]

MORE ON CORTEVA

* Corteva, Inc. (CTVA) Q2 2026 Earnings Call Transcript [https://seekingalpha.com/article/4928752-corteva-inc-ctva-q2-2026-earnings-call-transcript]
* Corteva: Strong Fundamentals, Limited Upside [https://seekingalpha.com/article/4928736-corteva-strong-fundamentals-limited-upside]
* Corteva, Inc. 2026 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4928669-corteva-inc-2026-q2-results-earnings-call-presentation]
* Corteva Non-GAAP EPS of $2.30 beats by $0.07, revenue of $6.38B misses by $220M [https://seekingalpha.com/news/4622161-corteva-non-gaap-eps-of-2_30-beats-by-0_07-revenue-of-6_38b-misses-by-220m]
* Corteva Q2 2026 Earnings Preview [https://seekingalpha.com/news/4620625-corteva-q2-2026-earnings-preview]